Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) insider Nicholas Hollmeyer Lynton sold 3,377 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $3.19, for a total value of $10,772.63. Following the completion of the transaction, the insider now directly owns 94,706 shares in the company, valued at approximately $302,112.14. This trade represents a 3.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Nicholas Hollmeyer Lynton also recently made the following trade(s):
- On Friday, January 3rd, Nicholas Hollmeyer Lynton sold 6,464 shares of Cardlytics stock. The stock was sold at an average price of $3.67, for a total transaction of $23,722.88.
Cardlytics Stock Performance
CDLX stock traded down $0.10 during midday trading on Thursday, reaching $3.06. 687,561 shares of the company’s stock traded hands, compared to its average volume of 1,027,198. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. Cardlytics, Inc. has a 52 week low of $2.76 and a 52 week high of $20.52. The firm has a market capitalization of $155.51 million, a PE ratio of -0.50 and a beta of 1.53. The company has a 50-day moving average price of $3.64 and a two-hundred day moving average price of $4.26.
Institutional Trading of Cardlytics
Institutional investors and hedge funds have recently made changes to their positions in the stock. Atom Investors LP bought a new stake in Cardlytics in the 3rd quarter worth approximately $33,000. Tallon Kerry Patrick purchased a new stake in Cardlytics during the 4th quarter valued at $37,000. SG Americas Securities LLC bought a new stake in shares of Cardlytics in the third quarter worth about $45,000. Intech Investment Management LLC bought a new stake in shares of Cardlytics in the 3rd quarter worth approximately $47,000. Finally, Quadrature Capital Ltd purchased a new position in Cardlytics during the 3rd quarter valued at $63,000. Hedge funds and other institutional investors own 68.10% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. Evercore ISI began coverage on shares of Cardlytics in a research report on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target for the company. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Cardlytics has an average rating of “Hold” and a consensus target price of $6.92.
View Our Latest Research Report on Cardlytics
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Read More
- Five stocks we like better than Cardlytics
- Why is the Ex-Dividend Date Significant to Investors?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Bank Stocks – Best Bank Stocks to Invest In
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Buy P&G Now, Before It Sets A New All-Time High
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.